引言在与癌症的博弈中,研究人员始终在追寻肿瘤细胞的致命弱点。传统T细胞疗法如同精密制导武器,通过识别癌细胞表面的突变抗原来发动攻击,却在实体瘤治疗中屡屡碰壁:肿瘤内部如同错综复杂的迷宫,不同区域的癌细胞携带迥异的基因突变(肿瘤异质性),而低突变负荷的 ...
Al Charest is in the Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. Read the paper: Tumour-wide RNA splicing aberrations ...